ANGIODYNAMICS INC (ANGO)
Data as of , from SEC Form 4 filings.
See up to 3 months of ANGO. The 7-day demo opens the 1M and 3M ranges and puts ANGO on your watchlist.
Start 7-day demoLatest ANGO insider trades
About ANGIODYNAMICS INC (ANGO)
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
- LATHAM, NY
- 632
- 2004
- XNAS
ANGO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 23,370 | $344K |
| Grant or award | 17 | 340,113 | |
| Option exercise | 10 | 401,759 | |
ANGO insider transactions (Form 4)
3350 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tax withholding / forfeiture | Common Stock | 344 | $8.69 | $3K | ||
| Tax withholding / forfeiture | Common Stock | 8,307 | $8.69 | $72K | ||
| Tax withholding / forfeiture | Common Stock | 2,982 | $8.69 | $26K | ||
| Tax withholding / forfeiture | Common Stock | 3,673 | $8.99 | $33K | ||
| Chad Thomas Campbell - Officer | Tax withholding / forfeiture | Common Stock | 1,025 | $8.69 | $9K | |
| Chad Thomas Campbell - Officer | Tax withholding / forfeiture | Common Stock | 359 | $8.69 | $3K | |
| Chad Thomas Campbell - Officer | Tax withholding / forfeiture | Common Stock | 395 | $8.99 | $4K | |
| Tax withholding / forfeiture | Common Stock | 3,074 | $8.74 | $27K | ||
| Grant or award | Common Stock | 32,423 | $0.00 | - | ||
| Grant or award | Performance Right | 32,423 | $0.00 | - | ||
| Warren Nighan Jr. - Officer | Grant or award | Common Stock | 29,349 | $0.00 | - | |
| Warren Nighan Jr. - Officer | Grant or award | Performance Right | 29,349 | $0.00 | - | |
| Grant or award | Common Stock | 30,900 | $0.00 | - | ||
| Grant or award | Performance Right | 30,900 | $0.00 | - | ||
| Grant or award | Common Stock | 206,253 | $0.00 | - | ||
| Grant or award | Performance Right | 206,253 | $0.00 | - | ||
| Grant or award | Common Stock | 86,997 | $0.00 | - | ||
| Grant or award | Performance Right | 86,997 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Chad Thomas Campbell - Officer | Grant or award | Common Stock | 26,268 | $0.00 | - | |
| Chad Thomas Campbell - Officer | Grant or award | Performance Right | 26,268 | $0.00 | - | |
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 17,675 | $0.00 | - | ||
| Grant or award | Common Stock | 52,697 | $0.00 | - | ||
| Grant or award | Non-Qualified Stock Option (right to buy) | 103,650 | $0.00 | - | ||
| Warren Nighan Jr. - Officer | Open-market purchase | Common Stock | 768 | $6.09 | $5K | |
| Warren Nighan Jr. - Officer | Open-market purchase | Common Stock | 100 | $6.08 | $608 | |
| Open-market purchase | Common Stock | 20,000 | $6.03 | $121K | ||
| Open-market purchase | Common Stock | 1,700 | $5.86 | $10K |
Recent ANGO Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Stock trades in ANGO disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
ANGO insider trading FAQ
What is the latest insider trade for ANGO?
ANGIODYNAMICS INC (ANGO) had 24 insider filings in the last 90 days, with the most recent on 2026-07-31. The full record for ANGO runs to 50 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ANGO stock?
No insider purchases of ANGO were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling ANGO stock?
1 insider sale of ANGO was filed in the last 90 days, totaling $344K.
Where can I see ANGO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ANGO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Warren Nighan Jr. view on EDGAR
- - Laura Piccinini view on EDGAR
- - Warren Nighan Jr. view on EDGAR
- - Stephen A. Trowbridge view on EDGAR
- - James C. Clemmer view on EDGAR
- - Chad Thomas Campbell view on EDGAR
- - Jan Stern Reed view on EDGAR
- - Karen A. Licitra view on EDGAR
- - Wesley Johnson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ANGO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ANGO with a 7-day demo
- ANGO on your watchlist
- Every ANGO Form 4 filing on record
- Up to 3 months of ANGO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive